CTKB
CTKB
NASDAQ · Life Sciences Tools & Services

Cytek Biosciences Inc

$5.30
+0.09 (+1.73%)
As of Sep 20, 10:23 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +963.8% upside
Low Target $40.67
Average Target $56.38
High Target $70.69
Current Price $5.30
Current
$5.30
Target
$56.38
$40.67 $56.38 avg $70.69
Scenario Analysis
Bear Case
$40.67
667.4%
Low target
Base Case
$56.38
+963.8%
Avg target
Bull Case
$70.69
+1,233.8%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$6.18
-14.2% from high
52-Week Low
$3.28
+61.6% from low
Target vs 52W High
$56.38
+812.3% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -45.6%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -29.3%
IQV
Iqvia Holdings Inc
Strong Buy 28 82% $82.96 -69.8%
A
Agilent Technologies Inc
Strong Buy 30 77% $64.69 -62.6%
WAT
Waters Corp
Buy 31 65% $189.60 -55.9%
ILMN
Illumina Inc
Buy 28 57% $169.36 -38.2%
MTD
Mettler-Toledo International
Hold 19 53% $170.43 -88.8%
WST
West Pharmaceutical Services
Strong Buy 23 91% $136.24 -63.5%